162 Invivoscribe 2019 | 163 Notes Ver. C Warranty and Liability Limits Invivoscribe, Inc (Invivoscribe® ) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe® . Invivoscribe® liability shall not exceed the purchase price of the product. Invivoscribe® shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph. Intended Uses Research Use Only products have not been approved by any regulatory agency for clinical use and are not for diagnostic or therapeutic use. Our CE-marked IdentiClone™ assays, sold in Europe and not for sale or use in the United States, are in vitro Diagnostic devices intended for detection of clonal gene rearrangements and translocations for patients with suspected lymphoproliferations. Patent Notice Many of the products described herein are covered by one or more of the following: European Patent Number 1549764, European Patent Number 2418287, European Patent Number 2460889, Japanese Patent Number 4708029, United States Patent No. 7,785,783, United States Patent 8859748, and related pending and future applications. All of these patents and applications are licensed exclusively to Invivoscribe® . Additional patents licensed to Invivoscribe covering some of these products apply elsewhere, or as described in this catalog. Use of these products may require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). Any necessary license to practice amplification methods or to use amplification enzymes or equipment covered by third party patents is the responsibility of the user and no such license is granted by Invivoscribe® , expressly or by implication. Notice ©2019 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe® , and/or its affiliates, or (as to the trademarks of others used herein) their respective owners. • ILLUMINA® and MISEQ® are registered trademarks of Illumina, Inc. • THERMO FISHER SCIENTIFIC® and ION PGM™ and ION S5™ are trademarks of Thermo Fisher Scientific or its subsidiaries. • AGILENT® and BIOANALYZER® are registered trademarks of Agilent Technologies, Inc. • KAPA™ is a trademark of Kapa Biosystems. • PERKIN ELMER® and LABCHIP® are registered trademark of Perkin Elmer. • MICROSOFT® , WINDOWS® , and EXCEL® are registered trademarks of Microsoft Corporation. • Roche® is a registered trademark of F. Hoffmann-La Roche Ltd.